{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:56:19Z","timestamp":1785257779503,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"F2G, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The nationwide attributable mortality of aspergillosis in the era of mold-active triazoles is poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from the US National Vital Statistics System for 2018-2024. Aspergillosis-attributable mortality was identified using an International Classification of Diseases-10th Revision (ICD-10) diagnosis code of B44.x listed anywhere on the death certificate. We present age-adjusted mortality rates (AAMRs)\/1 000 000 persons with 95% confidence intervals (CIs) for aspergillosis deaths and stratified by demographics. Risk ratios (RRs) were used to compare AAMRs across strata and the proportion of key comorbidities included on aspergillosis versus non-aspergillosis certificates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 7063 aspergillosis-attributable deaths identified (AAMR: 2.43, 2.37-2.49). Of these, 1551 (22.0%) of death certificates had aspergillosis listed as the primary cause. An invasive aspergillosis (IA) disease code was most often listed (n = 4880 certificates); specifically, \u201cother pulmonary aspergillosis\u201d (B44.1, n = 4292 certificates). Unspecified aspergillosis was listed on 2139 death certificates. Non-IA codes were rarely observed (n = 73 certificates). Aspergillosis deaths increased in later years of analysis (AAMR range: 2.50-3.01) versus 2018-2020 (AAMR: 2.01). Nearly 60% of aspergillosis deaths occurred in those \u226565-years-old, and the AAMR was higher in males (RR: 1.64, 1.50-1.80). Neither race nor ethnicity was associated with differences in AAMR. AAMRs varied across states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients with a death certificate with aspergillosis, primary attributable mortality was 22.0%. Our results may be useful as experts seek to better understand the true epidemiology of IA, develop efforts to raise disease awareness, and reduce IA-related mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf653","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T12:54:57Z","timestamp":1763816097000},"page":"86-92","source":"Crossref","is-referenced-by-count":2,"title":["Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data"],"prefix":"10.1093","volume":"82","author":[{"given":"Thomas J","family":"Walsh","sequence":"first","affiliation":[{"name":"Departments of Medicine and Microbiology and Immunology, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Office of the Director, Center for Innovative Therapeutics and Diagnostics , Richmond, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakota","family":"Sicignano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, University of Connecticut , Storrs, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9404-1018","authenticated-orcid":false,"given":"Matthew","family":"Mastropietro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, University of Connecticut , Storrs, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Lovelace","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, F2G, Inc , Princeton, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-7158","authenticated-orcid":false,"given":"Craig I","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, University of Connecticut , Storrs, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2026020904065225400_ciaf653-B1","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMra2027424","article-title":"Aspergillus infections","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"key":"2026020904065225400_ciaf653-B2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/ciy181","article-title":"Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009\u20132013","volume":"67","author":"Zilberberg","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B3","doi-asserted-by":"crossref","first-page":"ofab593","DOI":"10.1093\/ofid\/ofab593","article-title":"Prevalence and healthcare burden of fungal infections in the United States, 2018","volume":"9","author":"Rayens","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2026020904065225400_ciaf653-B4","doi-asserted-by":"crossref","first-page":"ofae747","DOI":"10.1093\/ofid\/ofae747","article-title":"Association between the need to change initial antifungal therapy and treatment costs in patients with invasive aspergillosis","volume":"12","author":"Alexander","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026020904065225400_ciaf653-B5","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026020904065225400_ciaf653-B6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3121\/cmr.2015.1276","article-title":"Principles and pitfalls: a guide to death certification","volume":"13","author":"Brooks","year":"2015","journal-title":"Clin Med Res"},{"key":"2026020904065225400_ciaf653-B8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997","volume":"33","author":"McNeil","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciab336","article-title":"Mortality trends in risk conditions and invasive mycotic disease in the United States, 1999\u20132018","volume":"74","author":"Rayens","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B10","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1093\/cid\/ciac489","article-title":"Increased deaths from fungal infections during the coronavirus disease 2019 pandemic","volume":"76","author":"Gold","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B11","author":"National Center for Health Statistics"},{"key":"2026020904065225400_ciaf653-B12","author":"Centers for Disease Control and Prevention"},{"key":"2026020904065225400_ciaf653-B13","volume-title":"Age adjustment using the 2000 projected U.S. population. Healthy people statistical notes, no. 20","author":"Klein","year":"2001"},{"key":"2026020904065225400_ciaf653-B14","author":"Centers for Disease Control and Prevention"},{"key":"2026020904065225400_ciaf653-B15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"2026020904065225400_ciaf653-B16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/jof11090623","article-title":"What is the prognostic significance of culture-documented breakthrough invasive pulmonary aspergillosis in patients with hematological malignancies? A propensity score-adjusted analysis","volume":"11","author":"Cho","year":"2025","journal-title":"J Fungi (Basel)"},{"key":"2026020904065225400_ciaf653-B17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026020904065225400_ciaf653-B19","author":"Centers for Disease Control and Prevention"},{"key":"2026020904065225400_ciaf653-B20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/13693780903262105","article-title":"Spatio-temporal and healthcare trends of non-endemic, invasive fungal infections in the United States, National Hospital Discharge Survey\u20131996 to 2006","volume":"48","author":"Panackal","year":"2010","journal-title":"Med Mycol"},{"key":"2026020904065225400_ciaf653-B21","doi-asserted-by":"crossref","first-page":"O939","DOI":"10.1111\/1469-0691.12650","article-title":"Environmental variables associated with an increased risk of invasive aspergillosis","volume":"20","author":"Garcia-Vidal","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2026020904065225400_ciaf653-B22","doi-asserted-by":"crossref","first-page":"ofad345","DOI":"10.1093\/ofid\/ofad345","article-title":"Trends of azole antifungal prescription in the United States: Medicare part D provider utilization and payment data analysis","volume":"10","author":"Al-Obaidi","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026020904065225400_ciaf653-B23","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1097\/TP.0000000000005082","article-title":"Isavuconazole versus voriconazole as the first-line therapy for solid organ transplant recipients with invasive aspergillosis: comparative analysis of 2 multicenter cohort studies","volume":"108","author":"Fern\u00e1ndez-Ruiz","year":"2024","journal-title":"Transplantation"},{"key":"2026020904065225400_ciaf653-B24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026020904065225400_ciaf653-B25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.chest.2018.01.025","article-title":"Point: is ICD-10 diagnosis coding important in the era of big data? Yes","volume":"153","author":"Weiner","year":"2018","journal-title":"Chest"},{"key":"2026020904065225400_ciaf653-B26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/524324","article-title":"Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis","volume":"29","author":"Chang","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026020904065225400_ciaf653-B27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jcp-2023-208876","article-title":"Accuracy and validity of determined cause of death and manner of death following forensic autopsy prosection","volume":"77","author":"Shergill","year":"2024","journal-title":"J Clin Pathol"},{"key":"2026020904065225400_ciaf653-B28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.5858\/2005-129-1476-DCEAAA","article-title":"Death certification errors at an academic institution","volume":"129","author":"Pritt","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"2026020904065225400_ciaf653-B29","first-page":"215","article-title":"Administrative databases and outcomes assessment: an overview of issues and potential utility","volume":"5","author":"Gandhi","year":"1999","journal-title":"J Manag Care Pharm"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf653\/65492522\/ciaf653.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/1\/86\/65492522\/ciaf653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/1\/86\/65492522\/ciaf653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:07:02Z","timestamp":1770628022000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/1\/86\/8341564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf653","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,15]]},"published":{"date-parts":[[2025,11,24]]}}}